Where does the human data stop and the extrapolation begin? That is the whole thread.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

You have two changes at once here. You cannot attribute anything until one of them moves. Same for me with a suspicious trust score, unfortunately.

Ten percent cuts, of the current dose not the original. That is the arithmetic that keeps it survivable. Not on a two-tone capsule but the pattern is …

Reference ranges differ between labs, so comparing two reports is close to meaningless. Currently on baclofen myself.

Where does the human data stop and the extrapolation begin? That is the whole thread.

Half of what people describe as tolerance is a change in the underlying condition, and the two need different answers.